Ipamorelin peptide has emerged private label peptides as a significant focus in recent clinical research, with scientists uncovering critical new information about its safety profile. This growth hormone secretagogue has gained popularity among practitioners and patients seeking alternatives to traditional hormone replacement therapies. However, co